Want to join the conversation?
Analog system solutions provider $EXAR said on a sequential basis, 4Q16 non-GAAP revenue fell 2% to $36.8MM. It was directly impacted by the timing of $1.1MM of display shipments to the company's largest direct customer. Industrial revenue was 47% of sales. High-End Consumer revenue was 33% of sales while Infrastructure revenue was 20%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?